But then a 45-minute delay due to a technical issue left almost 100,000 people looking at a screen with a graphic of Johnson in a meditative posture on top of a lotus beneath the banner The Ascension of Unc, as handpan music drifted in and out
GLP-1 medications like semaglutide slow gastric emptying and can influence cardiovascular function through appetite suppression
The STEP-1 extension trial followed patients who had lost weight on semaglutide and then switched to placebo
BPC-157 may be worth exploring for: Men recovering from tendon, ligament, or muscle injuries Those experiencing chronic joint pain or inflammation Men on TRT who train intensely and want additional recovery support Individuals with gastrointestinal issues (gut inflammation, leaky gut, NSAID damage) Those interested in peptide therapy as part of a comprehensive wellness protocol Who Should Avoid BPC-157 Anyone with active cancer (BPC-157s angiogenic properties could theoretically promote tumor blood supply) Individuals allergic to any component of the peptide formulation Those unwilling to undergo medical supervision Anyone expecting BPC-157 to replace testosterone therapy for hypogonadism References Sikiric P, Seiwerth S, Rucman R, et al
Can Semaglutide GLP-1 and Ozempic be used together for better results
A Functional Medicine Take On the Latest Research The peptide semaglutide (sold as Ozempic, Wegovy, or Rybelsus) is famous for its use as a weight loss drug and to treat type 2 diabetes